BPC-157 · 10 mg
Pentadecapeptide studied extensively in tissue-repair and angiogenesis models.
$55.00$89.00
Recovery & Repair
ARA-290 (Cibinetide) 9 mg
$54.00$94.0099.2% purity · Batch ARA-260818
Erythropoietin-derived nonapeptide studied in innate repair receptor and tissue-protection research.
Lot analysis published for this batch. Independent Janoshik Analytical testing (Sep 2026) — purity, content and endotoxin, shown unedited further down this page.1
- Third-party HPLC & mass-spec verified
- Same-day dispatch before 2 PM ET
- Cold-packed, tamper-sealed shipping
- Batch-coded and dated at fill
Research background
ARA-290 (cibinetide) is an 11-residue peptide derived from the helix-B domain of erythropoietin, investigated in research on the innate repair receptor (EPOR–CD131 heteroreceptor) and tissue-protective signalling without erythropoietic activity. Supplied lyophilised in a sealed, lot-coded vial with the published lot report.
Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.
Lot analysis for this batch
- Lot
- ARA-260818
- Purity (3 vials)
- 99.23 / 99.21 / 99.22 %
- Content (3 vials)
- 8.90 / 9.24 / 9.03 mg
- Endotoxin
- 6.914 EU/vial
- Tested by
- Janoshik Analytical, Sep 2026
Published in full and unedited — verify it with the key printed on the report.
Specifications
- Molecular formula
- C51H84N16O21
- Molar mass
- 1257.3 g/mol
- Form
- Lyophilised white powder
- Storage
- -20 °C, protect from light
- Certificate of analysis
- View batch ARA-260818
More in Recovery & Repair
TB-500 · 10 mg
Thymosin beta-4 fragment used in cell-migration and wound-model research.
$62.00$99.00
BPC-157 / TB-500 Repair Blend · 20 mg
Co-lyophilised 10 mg BPC-157 with 10 mg TB-500 in a single vial.
$90.00$159.00
ARA-290 (Cibinetide) 9 mg
$54.00